Objectives: In this study, we aimed to compare the levels of maternal blood lipids, placental and venous blood lipid transporters, and inflammatory factor receptors in pregnant women with and without gestational diabetes mellitus (GDM). We also aimed to figure out the relationship between these values and neonatal weight. Methods: Fifty pregnant women with GDM under blood glucose control belong to the case group, and 50 pregnant women with normal glucose tolerance in concurrent delivery belong to the control group. Fasting venous blood of these pregnant women was taken 2 weeks before delivery, and umbilical cord blood was collected after delivery. The levels of triglyceride (TG), serum total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol (HDL-C) in maternal blood and umbilical cord blood were tested in the laboratory department of our hospital. The level of toll-like receptor 4 (TLR4) in serum of umbilical veins was detected by the double-antibody sandwich ELISA. Western blot and RT-PCR were used to detect the protein and mRNA expressions of TLR4, LPL, and FAT/CD36 in the placenta. Results: The level of TG in maternal blood in the case group was remarkably higher than that in the control group, which was opposite to the level of HDL-C. In the umbilical cord blood of women with GDM, the expression of TLR4 increased and was closely correlated with neonatal weight. In the placenta of women with GDM, the expressions of FAT/CD36 and TLR4 increased, and both of them were closely correlated with neonatal weight. Besides, TLR4 in umbilical cord blood increased and was closely correlated with neonatal weight. Although the expression of LPL in the placenta decreased, it had no obvious correlation with neonatal weight. Conclusions: TG in maternal blood, TLR4 in the placenta and umbilical cord blood, and FAT/CD36 in the placenta were positively correlated with neonatal weight. However, HDL-C in maternal blood was negatively correlated with neonatal weight. Although the expression of LPL in the placenta reduced due to GDM, it had no correlation with neonatal weight.

1.
Eades
CE
,
Cameron
DM
,
Evans
JMM
.
Prevalence of gestational diabetes mellitus in Europe: a meta-analysis
.
Diabetes Res Clin Pract
.
2017
;
129
:
173
81
. .
2.
Na
R
,
Li
D
,
Mi
L
,
Liang
H
, et al
Prevalence rate of gestational diabetes mellitus in China: a meta-analysis
.
Chin J Evid-Based Med
.
2018
;
18
(
3
):
280
5
.
3.
Zhang
C
,
Bao
W
,
Rong
Y
,
Yang
H
,
Bowers
K
,
Yeung
E
, et al
Genetic variants and the risk of gestational diabetes mellitus: a systematic review
.
Hum Reprod Update
.
2013
;
19
(
4
):
376
90
. .
4.
Herath
H
,
Herath
R
,
Wickremasinghe
R
.
Gestational diabetes mellitus and risk of type 2 diabetes 10 years after the index pregnancy in Sri Lankan women—A community based retrospective cohort study
.
PLoS One
.
2017
;
12
(
6
):
e0179647
. .
5.
Bellamy
L
,
Casas
JP
,
Hingorani
AD
,
Williams
D
.
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
.
Lancet
.
2009
;
373
(
9677
):
1773
9
. .
6.
Kc
K
,
Shakya
S
,
Zhang
H
.
Gestational diabetes mellitus and macrosomia: a literature review
.
Ann Nutr Metab
.
2015
;
66
(
Suppl 2
):
14
20
. .
7.
Association
AD
.
Gestational diabetes mellitus 2004
.
Diabetes Care
.
2004
;
27
:
s88
90
.
8.
Davidson
M
,
Liu
SX
,
Barter
P
,
Brinton
EA
,
Cannon
CP
,
Gotto
AM
, et al
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib
.
J Lipid Res
.
2013
;
54
(
2
):
467
72
. .
9.
Dasu
MR
,
Devaraj
S
,
Park
S
,
Jialal
I
.
Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects
.
Diabetes Care
.
2010
;
33
(
4
):
861
8
. .
10.
Davis
JE
,
Gabler
NK
,
Walker-Daniels
J
,
Spurlock
ME
.
TLR-4 deficiency selectively protects against obesity induced by diets high in saturated fat: obesity
.
Silver
.
2008
;
16
:
1248
55
.
11.
Kuzmicki
M
,
Telejko
B
,
Wawrusiewicz-Kurylonek
N
,
Lipinska
D
,
Pliszka
J
,
Wilk
J
, et al
The expression of genes involved in NF-κB activation in peripheral blood mononuclear cells of patients with gestational diabetes
.
Eur J Endocrinol
.
2013
;
168
(
3
):
419
27
. .
12.
Yang
H
,
Xu
X
,
Wang
Z
,
Sun
W
,
Hu
Y
,
Chen
W
, et al
Guidelines for diagnosis and treatment of gestational diabetes mellitus
.
Diabetes World
.
2014
;
8
(
11
):
489
98
.
13.
Oliveira
D
,
Pereira
J
,
Fernandes
R
.
Metabolic alterations in pregnant women: gestational diabetes
.
J Pediatr Endocrinol Metab
.
2012
;
25
(
9–10
):
835
42
. .
14.
Bampi
AB
,
Rochitte
CE
,
Favarato
D
,
Lemos
PA
,
da Luz
PL
.
Comparison of non-invasive methods for the detection of coronary atherosclerosis
.
Clinics
.
2009
;
64
(
7
):
675
82
. .
15.
Danielsen
I
,
Granström
C
,
Haldorsson
T
,
Rytter
D
,
Hammer Bech
B
,
Henriksen
TB
, et al
Dietary glycemic index during pregnancy is associated with biomarkers of the metabolic syndrome in offspring at age 20 years
.
Plos One
.
2013
;
8
(
5
):
e64887
. .
16.
Schaefer-Graf
UM
,
Meitzner
K
,
Ortega-Senovilla
H
,
Graf
K
,
Vetter
K
,
Abou-Dakn
M
, et al
Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies
.
Diabet Med
.
2011
;
28
(
9
):
1053
9
. .
17.
Lu
X
.
The relationship of blood levels in leptin, insulin-like growth factor 1, lipid with fetal growth and development
.
Hebei United University
;
2014
.
18.
Wang
X
,
Li
J
,
Liu
W
,
Xie
X
,
Xu
J
, et al
Study on the differences of leptin, IGF-1 and blood lipids levels in maternal blood and umbilical cord blood between FGR neonates and normal neonates
.
Matern Child Health Care China
.
2018
;
33
(
23
):
5461
6
.
19.
Huang
H
,
Chen
Y
.
Difference between maternal blood and umbilical cord blood and its influence on the growth and development of newborns
.
Chin Gen Pract
.
2016
;
19
(
8
):
908
11
.
20.
Huang
Y
,
Li
X
,
Wang
M
,
Ning
H
,
A
L
,
Li
Y
, et al
Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study
.
Cardiovasc Diabetol
.
2013
;
12
:
17
7
. .
21.
Jay
JA
,
Hamilton
JA
.
The enigmatic membrane fatty acid transporter CD36: new insights into fatty acid binding and their effects on uptake of oxidized LDL
.
Prostaglandins Leukot Essent Fatty Acids
.
2018
;
138
:
64
70
. .
22.
Radaelli
T
,
Lepercq
J
,
Varastehpour
A
,
Basu
S
,
Catalano
PM
,
Hauguel-De Mouzon
S
.
Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus
.
Am J Obstet Gynecol
.
2009
;
201
(
2
):
209
e10
. .
23.
Ruiz-Palacios
M
,
Prieto-Sánchez
MT
,
Ruiz-Alcaraz
AJ
,
Blanco-Carnero
JE
,
Sanchez-Campillo
M
,
Parrilla
JJ
, et al
Insulin treatment may alter fatty acid carriers in placentas from gestational diabetes subjects
.
Int J Mol Sci
.
2017
;
18
(
6
):
1203
. .
24.
Barrett
HL
,
Kubala
MH
,
Scholz Romero
K
,
Denny
KJ
,
Woodruff
TM
,
McIntyre
HD
, et al
Placental lipases in pregnancies complicated by gestational diabetes mellitus (GDM)
.
PLoS One
.
2014
;
9
(
8
):
e104826
. .
25.
Magnusson-Olsson
AL
,
Lager
S
,
Jacobsson
B
,
Jansson
T
,
Powell
TL
.
Effect of maternal triglycerides and free fatty acids on placental LPL in cultured primary trophoblast cells and in a case of maternal LPL deficiency
.
Am J Physiol Endocrinol Metab
.
2007
;
293
(
1
):
E24
30
. .
26.
Segura
MT
,
Demmelmair
H
,
Krauss-Etschmann
S
,
Nathan
P
,
Dehmel
S
,
Padilla
MC
, et al
Maternal BMI and gestational diabetes alter placental lipid transporters and fatty acid composition
.
Placenta
.
2017
;
57
:
144
51
. .
27.
Freeman
DJ
,
Norrie
J
,
Sattar
N
,
Neely
RD
,
Cobbe
SM
,
Ford
I
, et al
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study
.
Circulation
.
2001
;
103
(
3
):
357
62
. .
28.
Fan
G
,
Jiang
X
,
Wu
X
,
Fordjour
PA
,
Miao
L
,
Zhang
H
, et al
Anti-inflammatory activity of tanshinone IIA in LPS-stimulated RAW264.7 macrophages via miRNAs and TLR4-NF-kappaB pathway
.
Inflammation
.
2016
;
39
(
1
):
375
84
.
29.
Giannoukakis
N
,
Rudert
WA
,
Trucco
M
,
Robbins
PD
.
Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor
.
J Biol Chem
.
2000
;
275
(
47
):
36509
13
. .
30.
Vitoratos
N
,
Valsamakis
G
,
Mastorakos
G
,
Boutsiadis
A
,
Salakos
N
,
Kouskouni
E
, et al
Pre- and early post-partum adiponectin and interleukin-1beta levels in women with and without gestational diabetes
.
Hormones
.
2008
;
7
(
3
):
230
6
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.